Research progress of monoclonal antibody in the treatment of adult acute lymphoblastic leukemia:reports from the 55th ASH annual meeting / 白血病·淋巴瘤

ABSTRACT

Humanized monoclonal antibody and CARs have became the focus of treatment in adult acute lymphoblastic leukemia (ALL) at the 55th ASH annual meeting.Treating with chemotherapy plus monoclonal antibody will get a develop effect in relapse/refractory adult ALL.More immune-pharmaceutics will be used in clinical trials.